Olaf Panknin

Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo

Stefan Pusch, Sonja Krausert, Viktoria Fischer et al. · Acta Neuropathologica · 2017 · 174 citations

Tumor Biology, Neuro-oncology, Glioma +10

Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo

Anuhar Chaturvedi, Lena Herbst, Stefan Pusch et al. · Leukemia · 2017 · 117 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +8

Proof of Principle in the Selective Treatment of Cancer by Antibody-Directed Enzyme Prodrug Therapy: The Development of a Highly Potent Prodrug This work was supported by the Deutsche Forschungsgemeinschaft (SFB 416) and by the Fonds der Chemischen Industrie.

Lutz F. Tietze, Tim Feuerstein, Anja Fecher et al. · Angewandte Chemie International Edition · 2002 · 55 citations

Immunology, Pharmacotherapy, Immunotherapy +18

Preclinical Profile of Gadoquatrane

Jessica Lohrke, Markus Berger, Thomas Frenzel et al. · Investigative Radiology · 2022 · 51 citations · Full text

Asymmetric [2,3]-Sigmatropic Rearrangement of Allylic Ammonium Ylides

Jan Blid, Olaf Panknin, Peter Somfai · Journal of the American Chemical Society · 2005 · 50 citations

Chiral Lewis Acid, Cross-coupling Reaction, Engineering +12